Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Narcolepsy and Hypersomnia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 0 results

Not applicableStudy completedNCT06531876
What this trial is testing

Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy

Who this might be right for
Narcolepsy Type 1HypersomniaSleep Disorder
Beacon Biosignals 78
Not applicableTemporarily pausedNCT04419792
What this trial is testing

'A Profile of Physical Performance Variables in an Out-patient Adult Population With Narcolepsy'

Who this might be right for
NarcolepsyNarcolepsy 1Narcolepsy Type 1+4 more
University of Dublin, Trinity College 70
Large-scale testing (Phase 3)Study completedNCT00078377
What this trial is testing

Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy

Who this might be right for
Narcolepsy
Cephalon 196
Large-scale testing (Phase 3)Study completedNCT02348632
What this trial is testing

"A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"

Who this might be right for
NarcolepsyObstructive Sleep Apnea
Jazz Pharmaceuticals 645
Testing effectiveness (Phase 2)Study completedNCT03881852
What this trial is testing

Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)

Who this might be right for
NarcolepsyCataplexy NarcolepsyExcessive Sleepiness
Axsome Therapeutics, Inc. 21